In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
Molecule AI is revolutionising drug discovery by using artificial intelligence to predict molecular combinations and ...
The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
Clinical trials are not just about testing medicines; they are about building the future of healthcare There is a dire need ...
A Senate hearing probed whether the Food and Drug Administration's process for approving rare-disease therapies is ...
Innovators are increasingly focused on whether outsourced partners can help them make better decisions earlier, before ...
New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the production of toxic amyloid beta peptides in the first place.
Chemists from St. Petersburg University has developed a new family of luminescent iridium complexes that, for the first time, realize a unique mechanism of photoactivated proton transfer. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results